Pseudoexfoliation and Carpal Tunnel Study
Launched by ANKARA TRAINING AND RESEARCH HOSPITAL · Apr 19, 2025
Trial Information
Current as of July 16, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Pseudoexfoliation syndrome (PES), first described by Lindberg in 1917, is a relatively common systemic disorder. While it primarily affects ocular tissue through gradual accumulation of fibrogranular material in the anterior segment of the eye, it can be observed in any other tissue. The chemical composition of the accumulated material is still not fully understood. Abnormal metabolism and overproduction of glycosaminoglycans are thought to play a key role. PES is commonly seen in males and individuals over 60 years of age, with incidence varying according to race and geographical character...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being between the ages of 18-90
- • Having been diagnosed with PES during routine eye examination
- Exclusion Criteria:
- • History of major hand-wrist trauma or surgical intervention
- • Acromegaly
- • Presence of any structural abnormality in bone structure
- • Pregnancy
- • Diabetes mellitus
- • Gout
- • Rheumatoid arthritis
- • Connective tissue disease
- • Acromegaly
- • Thoracic outlet syndrome
- • Brachial plexopathy
- • Cervical disc herniation
- • Presence of cardiac pacemaker
- • Steroid users
- • Thyroid disease
- • Repetitive hand operations
About Ankara Training And Research Hospital
Ankara Training and Research Hospital is a leading medical institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital is committed to enhancing patient outcomes by exploring new therapies and medical interventions across a variety of disciplines. With state-of-the-art facilities and a multidisciplinary team of experienced professionals, Ankara Training and Research Hospital prioritizes patient safety and ethical standards while contributing to the global body of medical knowledge. Their collaborative approach fosters partnerships with academic institutions and industry stakeholders, ensuring rigorous research methodologies and the effective translation of findings into clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, Altindag, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported